Publications by authors named "Elizabeth A Raetz"

Claim this Profile
D
Diminished Quality of Life Despite Reduced Treatment in Children With B-Lymphoblastic Leukemia: Children's Oncology Group AALL0932.
Lyn M Balsamo, John A Kairalla, Emily Hibbitts, Rozalyn L Rodwin, Meenakshi Devidas, Elizabeth A Raetz

Pediatr Blood Cancer· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434.
Robert J Hayashi, Stuart S Winter, Kimberly P Dunsmore, Meenakshi Devidas, Zhiguo Chen, Elizabeth A Raetz

J Clin Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group AALL1331 trial.
Laura E Hogan, Teena Bhatla, Xinxin Xu, Lia Gore, Elizabeth A Raetz

Haematologica· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children's Oncology Group report.
John A Ligon, Lingyun Ji, Alice Dang, Xinxin Xu, Susan R Rheingold, Elizabeth A Raetz

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inferring chromosome segregation error stage and crossover in trisomic disorders with application to Down syndrome.
Zhenhua Li, Wenjian Yang, Gang Wu, Ti-Cheng Chang, Zhongshan Cheng, Elizabeth A Raetz

Nat Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcome.
Changya Chen, Jason Xu, Jonathan H Sussman, Tiffaney Vincent, Joseph S Tumulty, Elizabeth A Raetz

Blood· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of Two-Phase Designs for the Time-to-Event Outcome and a Case Study Assessing the Relapse Risk Associated With B-ALL Subtypes.
Wenan Chen, Ti-Cheng Chang, Karen R Rabin, Elizabeth A Raetz, Meenakshi Devidas

JCO Clin Cancer Inform· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Accurate Determinants of Outcome in ALL.
Ti-Cheng Chang, Wenan Chen, Chunxu Qu, Zhongshan Cheng, Abdelrahman Elsayed, Elizabeth A Raetz

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children.
Sumit Gupta, Rachel E Rau, John A Kairalla, Karen R Rabin, Cindy Wang, Elizabeth A Raetz

N Engl J Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant Erwinia asparaginase (JZP458) in ALL/LBL: complete follow-up of the Children's Oncology Group AALL1931 study.
Luke Maese, Mignon L Loh, Mi Rim Choi, Shirali Agarwal, Etsuko Aoki, Elizabeth A Raetz

Blood Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multiomic atlas identifies a treatment-resistant, bone marrow progenitor-like cell population in T cell acute lymphoblastic leukemia.
Jason Xu, Changya Chen, Jonathan H Sussman, Satoshi Yoshimura, Tiffaney Vincent, Elizabeth A Raetz

Nat Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed -rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1.
Erin M Guest, John A Kairalla, Meenakshi Devidas, Emily Hibbitts, Andrew J Carroll, Elizabeth A Raetz

Haematologica· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study.
Teena Bhatla, Laura E Hogan, David T Teachey, Francisco Bautista, John Moppett, Elizabeth A Raetz

Blood· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children's Oncology Group study.
Susan R Rheingold, Deepa Bhojwani, Lingyun Ji, Xinxin Xu, Meenakshi Devidas, Elizabeth A Raetz

Leukemia· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to C.T. Matava et al.
Sarah Alexander, John A Kairalla, Sumit Gupta, Emily Hibbitts, Hannah Weisman, Elizabeth A Raetz

J Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Determinants of Outcome in Acute Lymphoblastic Leukemia.
Ti-Cheng Chang, Wenan Chen, Chunxu Qu, Zhongshan Cheng, Dale Hedges, Elizabeth A Raetz

J Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Propofol Exposure on Neurocognitive Outcomes in Children With High-Risk B ALL: A Children's Oncology Group Study.
Sarah Alexander, John A Kairalla, Sumit Gupta, Emily Hibbitts, Hannah Weisman, Elizabeth A Raetz

J Clin Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal evolution of the 3D chromatin landscape in patients with relapsed pediatric B-cell acute lymphoblastic leukemia.
Sonali Narang, Yohana Ghebrechristos, Nikki A Evensen, Nina Murrell, Sylwia Jasinski, Elizabeth A Raetz

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in children.
Carolin S Escherich, Wenan Chen, Yizhen Li, Wenjian Yang, Rina Nishii, Elizabeth A Raetz

Blood· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231.
Robert J Hayashi, Michelle L Hermiston, Brent L Wood, David T Teachey, Meenakshi Devidas, Elizabeth A Raetz

Blood· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of osteonecrosis and improved survival in B-ALL: results of Children's Oncology Group Trial AALL0232.
Leonard A Mattano, Meenakshi Devidas, Mignon L Loh, Elizabeth A Raetz, Zhiguo Chen

Leukemia· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group.
Karen R Rabin, Meenakshi Devidas, Zhiguo Chen, Lingyun Ji, John Kairalla, Elizabeth A Raetz

J Clin Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study.
Brent L Wood, Meenakshi Devidas, Ryan J Summers, Zhiguo Chen, Barbara Asselin, Elizabeth A Raetz

Blood· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1).
Elizabeth A Raetz, David T Teachey, Charles Minard, Xiaowei Liu, Robin E Norris

Pediatr Blood Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 infections in patients enrolled on the Children's Oncology Group standard-risk B-cell acute lymphoblastic leukemia trial, AALL1731.
Caitlin W Elgarten, John A Kairalla, Joel C Thompson, Tamara P Miller, Cindy Wang, Elizabeth A Raetz

EJHaem· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis